Chimeric Therapeutics Ltd. (AU:CHM) has released an update. Chimeric Therapeutics Ltd. has amended its company constitution, ...

Researchers at the Hebrew University of Jerusalem have developed an innovative approach to fight antibiotic-resistant ...

Chimeric Therapeutics Ltd. (AU:CHM) has released an update. Chimeric Therapeutics, a leading Australian cell therapy company, has appointed Dr.

T-cells are real life saviors. If modified properly, they can save lupus patients from the trouble of taking medicines ...

Engineered receptors could lead to more precisely targeted, effective cancer therapies with fewer side effects than existing ...

BioNTech has signed a definitive agreement to acquire Biotheus to obtain complete worldwide rights to BNT327/PM8002, a ...

*仅供医学专业人士阅读参考APOE4是阿尔茨海默病（AD）的最强遗传风险因素，降低AD发病年龄，促进AD的典型病理，包括β-淀粉样蛋白（Aβ）和过度磷酸化的tau蛋白（p-tau）沉积。APOE4在AD发病机制中的作用十分复杂，仍没有被完全揭示。星形 ...

通过VOS viewer软件进行关键词共现分析得出，多黏菌素B的抗菌机制、微生物耐药性机制与检测、多黏菌素B的药代动力学、多黏菌素B的临床应用尤其是脓毒症的临床应用为近年研究热点。WOS ...

Chimeric Therapeutics Ltd. (AU:CHM) has released an update. Chimeric Therapeutics made significant strides in its cell therapy programs, enrolling the first patient in its CHM CDH17 Phase 1/2 ...

Study: Beyond the blood: expanding CAR T cell therapy to solid tumors. Image Credit: Nemes Laszlo / Shutterstock In a recent ...

The Filipino-born artist takes a journey through primordial mud, chimeric worlds, and suppressed psychic demons to honor ...